Malawi vs Serbia, Republic of: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Malawi
91.0%
in 2025
Serbia, Republic of
91.0%
in 2025
Malawi rank
59th
Serbia, Republic of rank
59th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Malawi
- Serbia, Republic of
How they compare
Malawi currently reports 91.0% against 91.0% in Serbia, Republic of, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Serbia, Republic of ahead.
Malawi ranks 59th and Serbia, Republic of ranks 59th of 192 countries.
Malawi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Serbia, Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 72.1% | 15.9% | 56.2% | Malawi |
| 2020s | 91.2% | 87.5% | 3.7% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Malawi or Serbia, Republic of?
- Malawi, at 91.0% against 91.0% in Serbia, Republic of as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Malawi and Serbia, Republic of?
- 0.0%, with Malawi ahead.
- How many years of comparable data are there for Malawi and Serbia, Republic of?
- 18 years are reported by both, from 2008 to 2025.
- How do Malawi and Serbia, Republic of rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Malawi ranks 59th and Serbia, Republic of ranks 59th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.